$FOCL News

FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026

EDAP TMS S.A. (FOCL) Presents at H.C. Wainwright 28th Annual Global Investment Conference - Slideshow

HC Wainwright & Co. Reiterates Buy on Edap TMS, Maintains $10 Price Target

Edap TMS SA (FOCL) (Q2 2026) Earnings Call Highlights: HIFU Revenue Surges 39% as Company ...

FocalTherics Q2 Earnings Call Highlights

EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript

FocalTherics™ Reports Second Quarter 2026 Financial Results

Edap TMS Q2 2026 Earnings Call: Complete Transcript

FocalTherics Q2 EPS $(0.38) Misses $(0.20) Estimate, Sales $13.200M Miss $14.440M Estimate

FocalTherics shares are trading lower after the company announced the pricing of its $40 million offering of 8.425 million ADSs at $4.75 per ADS.

FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares

FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026

FocalTherics™ Announces Proposed Public Offering of American Depositary Shares

FocalTherics Reports Preliminary Q2 Sales Of $12.7M-$13.2M, Up 34%-39% Year-On-Year

FocalTherics Announces Underwritten Public Offering Of ADSs

FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026

FocalTherics Launches First European Commercial Endometriosis Focal One Program With Treatment Of Initial Patients In Toulouse, France

FocalTherics Expanding Focal One Robotic HIFU Access Under Signed Agreement With MellingMedical To Federal Healthcare Providers

EDAP TMS S.A. (FOCL) Analyst/Investor Day - Slideshow

HC Wainwright & Co. Reiterates Buy on FocalTherics, Maintains $10 Price Target